ESPR Cost of Revenue
Esperion Therapeutics Inc · Cost of Revenue
ESPR Cost of Revenue
Latest reported$146.39Mperiod ending
ESPR Cost of Revenue ($683.22K → $146.39M)
Annual cost of revenue
High-resolution chart · PNG
ESPR cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 129,223,999 | |
| 68,601,000 | |
| 43,267,000 | |
| 26,967,000 | |
| 14,217,000 | |
| 2,392,000 | |
| 0 | |
| 265,000 | |
| 258,000 | |
| 252,000 | |
| 236,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 786,000 | |
| 683,223 |